PerkinElmer

Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.

BioLegend is a biotechnology firm that offers immunological reagents for biomedical research. The company develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other biomedical research reagents in our state-of-the-art facility in San Diego, California.

Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery of new drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing. The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector. The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing.

Nexcelom Bioscience is a biotechnology company providing cell counting, image cytometry, and image analysis services. Nexcelom offers different Cellometer models to count and analyze cell lines and primary cells, through a bright field and fluorescence imaging modes. Also, Celigo is powerful in high image quality, high throughput image cytometry system for adherent and suspension cells in microwell plates.

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies. The company provides users with instruments and services, which enable multiplexing on planar array surfaces. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head. It was founded in 2005 and headquartered in Salt Lake City, Utah.

Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.

Cisbio Bioassays, a life sciences company, develops various assays and reagents for pharmaceutical, biotechnology, academia, and contract research organizations worldwide. It offers G-protein coupled receptor (GPCR), a homogeneous time-resolved fluorescence (HTRF) cellular platform solution; kinases and cell signaling solutions, such as assays for covering various needs for monitoring kinase targets; and a line of HTRF epigenetic toolbox reagents and kits for high throughput screening and investigation of epigenetic targets.

SSI is one of the manufacturers of analytical instruments in China. SSI delivers analytical solutions and services to a wide range of research, academic, government, pharmaceutical, industrial, life sciences and chemical analysis laboratories. Its portfolio includes photoelectric colorimeters, UV-Vis spectrophotometers, atomic absorption spectrophotometers and accessories.

RHS develops and markets biotechnology technologies primarily in Australia. Its lead products include EmbryoCellect, a preimplantation genetic screening solution; and DOPlif, a whole genome amplification kit.

EUROIMMUN AG develops and manufactures medical laboratory reagents for the diagnosis of autoimmune and infectious diseases and allergies. It offers indications for autoimmunity, infections, allergology, antigen detection, and molecular diagnostics; autoimmunity products for rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility; and infection products for immunity determination, CSF diagnostics, emerging viruses, avidity, BIOCHIP Mosaics for infectious serology, and others, as well as additional reagents for determination of acute infections.

Tulip Diagnostics is a domestic providers of in-vitro diagnostic reagents, kits and instruments.

Developer of a non-invasive prenatal testing (NIPT) solution in development that is based on digital analysis of cell-free DNA.

Ceiba Solutions develops informatics platforms and offers managed services to life sciences and health care industries.

Haoyuan, a supplier of molecular infectious disease screening technologies for blood bank and clinical laboratory settings throughout China, extends PerkinElmer's portfolio by adding four infectious disease assays that are approved by China's State Food and Drug Administration (SFDA).

Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The company's products also comprise LabChip 3000 Drug Discovery System, which produces data that minimizes false positives and false negatives, and detects weak inhibitors; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; MultiDose G3, an automated dissolution testing system; and active pharmaceutical ingredient workstation. In addition, it offers contract research and transgenic animal services, drug discovery and development services, product support, and validation services. Caliper Life Sciences sells its products through direct sales force and a network of distributors. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.

Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.

Labtronics Inc is a world leader in providing data integration solutions for laboratories in multiple industries. Combining an expertise in instrument integration and workflow automation allows Labtronics to deliver innovative solutions to solve the demanding needs of today's customers.

Geospiza Inc. develops software systems for workflow management of genetic analysis. It offers GeneSifter Analysis Edition, a cloud-based data analysis product for microarray and sequencing data; and GeneSifter Lab Edition, a software platform supporting laboratory workflows. The company serves laboratory, data management, and analytical needs of biotechnology and pharmaceutical companies, universities, researchers, contract core, and diagnostic laboratories involved in genetic testing and manufacturing bio-therapeutics. Geospiza, Inc. was founded in 1997 and is based in Seattle, Washington.

CambridgeSoft Corporation is a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company provides: Enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively. CambridgeSoft's products are used primarily in the pharmaceutical, biotechnology and chemical industries, as well as in higher education and in academic and government research. The company's principal software offering, Chem & Bio Office, which includes Chem & Bio Draw, is the de facto standard and primary communication tool on the chemist's desktop. Chem & Bio Office Enterprise, an enterprise implementation of Chem & Bio Office desktop, enables research information organizations to deploy application and information solutions using Internet, intranet, and extranet technologies

ArtusLabs is developing and deploying Web 2.0 enabled software platforms that enable groups of scientists, and thereby individual scientists, to deliver significantly better (and more) business value to their shareholders, faster. ArtusLabs was founded by the same proven team that formed Synthematix, the award winning organization that pioneered the Enterprise Electronic Lab Notebook marketplace. This leadership and development team has extensive expertise in processing, mining and managing complex scientific data and information generated from research activities. With a wealth of experience and very close relationships with scientists around the globe, the team at ArtusLabs continues to build the best collaborative customer experience and technologies for researchers -- hands down.

chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA, RNA, or viral DNA/RNA is facilitated through chemagen’s proprietary M-PVA Magnetic Bead technology.

VisEn Medical, Inc. designs, develops, and commercializes fluorescence in vivo imaging technology platforms. The company’s Fluorescence Molecular Tomographic (FMT) imaging systems and vivo imaging agents provide fluorescence molecular imaging performance in identifying, characterizing, and quantifying various ranges of disease biomarkers and therapeutic efficacy in vivo. It also provides ReninSense680, an imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo; and VivoTagR 680 XL fluorescent dye for labeling biomolecules in a range of in vitro and in vivo imaging applications. In addition, the company offers fluorescence tomographic imaging systems.

A Spokane, Wash.-based provider of molecular cytogenetic diagnostic services.

Surendra Genetic Labs, Pvt. Ltd. provides testing services for pregnant mothers and newborns. The company operates as laboratory, which focuses on fetal, maternal, and newborn health.

SYM-BIO Lifescience, a leading provider of diagnostics instruments and related reagents.

Analytica of Branford, Inc. develops and markets electrospray ion sources for mass spectrometry.

Opto Technology Inc. designs, develops, and manufactures optoelectronic and light-emitting diode (LED) related products.

rnel Inc., a recognized leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets. The acquisitionis an important strategic initiative to expand PerkinElmer's chromatography portfolio and strengthen its application-focused expertise to best serve the biofuels and hydrocarbon processing industries.

LabMetrix Technologies, Inc. provides metrology-based multi-vendor analytical instrument qualification solutions.

Pediatrix's screening reference laboratory and its StepOne® newborn screening product, which is capable of analyzing more than 50 inherited disorders in newborns, to its genetic screening product offerings. The laboratory provides neonatal screening and consultative services to five states and the District of Columbia, as well as to hospitals and medical groups.

ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is based in Boston, Massachusetts.

Applied Biosystems is a global leader in providing innovative instruments and reagents to accelerate academic and clinical research, drug discovery and development, pathogen detection, environmental analysis and forensic DNA analysis.